Katherine Jane Turner

USPTO Granted Patents = 14 (Patent Applications = 4)

EPO Patents = 2 (Patent Applications = 6)

Average Co-Inventor Count = 3.6

ph-index = 7

Forward Citations = 218(Granted Patents)

Location History:

New Albany, IN (US) (2001)
Melrose, MA (US) (1994 - 2008)
Acton, MA (US) (2006 - 2024)

Company Filing History:

Genetics Institute, Inc.

patents

1 out of 15

Nucryst Pharmaceuticals Corp.

patents

4. 1 out of 832,843

Other

patents

where one patent can have more than one assignee

Years Active: 1994-2025

Loading Chart...

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12281159 - TGFβ antibodies, methods and uses (2025-04-21),

2. 11925683 - Compositions for making and using anti-Myostatin antibodies (2024-03-12),

3. 11439704 - Methods for using anti-myostatin antibodies (2022-09-13),

4. 11135291 - Methods for making and using anti-myostatin antibodies (2021-10-05),

5. 10751413 - Anti-pro/latent-Myostatin antibodies and uses thereof (2020-08-25),

6. 10307480 - Anti-pro/latent-myostatin antibodies and uses thereof (2019-06-04),

7. 9260525 - Antibody molecules to oncogenic isoforms of fibroblast growth factor receptor-2 and uses thereof (2016-02-16),

8. 8425880 - Metal-containing materials for treatment of bacterial conditions (2013-04-23),

9. 7361738 - Megakaryocyte stimulating factors (2008-04-22),

10. 7034121 - Antibodies against CTLA4 (2006-04-25),

11. 7030223 - Megakaryocyte stimulating factors (2006-04-18),

12. 6433142 - Megakaryocyte stimulating factors (2002-08-13),

13. D446159 - Angel in bowl figurine (2001-08-08),

14. 5326558 - Megakaryocytopoietic factor (1994-07-05),

Title: **Innovative Contributions of Katherine Jane Turner: Pioneering Patents in Immunology**

Introduction

Katherine Jane Turner, an accomplished inventor based in Acton, Massachusetts, has made significant strides in the field of immunology with her innovative thinking and extensive research. With a remarkable portfolio of 14 patents, her work primarily focuses on developing novel therapeutic approaches for enhancing immune response.

Latest Patents

Turner's latest patents signify her commitment to advancing medical research. One notable patent involves TGFβ antibodies, specifically methods and uses related to proTGFβ1-GARP complex-selective antibodies. These innovative antibodies, alongside polynucleotides capable of encoding them, hold the potential to enhance immune responses against cancers. Another key patent pertains to compositions for creating and utilizing anti-Myostatin antibodies, showcasing her versatility in addressing critical health challenges.

Career Highlights

Throughout her career, Turner has collaborated with notable organizations, including Scholar Rock, Inc. and Genetics Institute, Inc. Her work at these institutions has not only fostered her innovation but has also contributed to pivotal developments in therapeutic solutions for various health implications.

Collaborations

Turner's professional journey has been marked by fruitful collaborations with esteemed colleagues, including Michelle Marie Straub and Steven C Clark. These partnerships have enriched her research endeavors and have played a pivotal role in the development of her patented technologies.

Conclusion

Katherine Jane Turner's contributions to immunology and her impressive portfolio of patents underline her status as a leading inventor in her field. Her innovative approaches not only enhance the understanding of immune responses but also pave the way for new therapeutic strategies aimed at combating serious health conditions. With ongoing research and collaboration, her work continues to inspire future innovations in the realm of medical science.

This text is generated by artificial intelligence and may not be accurate.